Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 6/20 | 0.51 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.43 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | CCR6 | P51684 | 1/20 | 0.40 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.40 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.39 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.39 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.39 |
| ▸ | TGM2 | P21980 | 1/20 | 0.38 |
| ▸ | MMP2 | P08253 | 1/20 | 0.38 |
| ▸ | MMP9 | P14780 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | ANPEP | P15144 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2030161 | 0.90 | FOLH1 (0.47) | FOLH1SLC1A3SLC1A1HTTCCR6 | |
| SCHEMBL2030163 | 0.90 | FOLH1 (0.47) | FOLH1SLC1A3SLC1A1HTTCCR6 | |
| SCHEMBL30350537 | 0.88 | FOLH1 (0.56) | FOLH1SLC1A3SLC1A1HTTCCR6 | |
| SCHEMBL29266083 | 0.88 | FOLH1 (0.46) | FOLH1SLC1A3SLC1A1HTTCCR6 | |
| SCHEMBL7767627 | 0.84 | FOLH1 (0.43) | FOLH1SLC1A3SLC1A1HTTCCR6 | |
| SCHEMBL5981757 | 0.82 | TPSAB1 (0.55) | FOLH1SLC1A3SLC1A1HTTSIRT2 | |
| SCHEMBL7762891 | 0.81 | FOLH1 (0.42) | FOLH1SLC1A3SLC1A1HTTCCR6 | |
| SCHEMBL29517152 | 0.80 | FOLH1 (0.42) | FOLH1SLC1A3SLC1A1SIRT2DPP8 | |
| SCHEMBL7353231 | 0.79 | HTT (0.41) | FOLH1SLC1A3SLC1A1HTTCCR6 | |
| Arginine SCHEMBL2515487 | 0.78 | SLC1A1 (0.47) | FOLH1SLC1A3SLC1A1HTTCCR6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2086531-A1 | COMPOSITIONS AND TREATMENTS COMPRISING 5-LIPOXYGENASE-ACTIVATING PROTEIN INHIBITORS AND NITRIC OXIDE MODULATORS | Amira Pharmaceuticals, Inc. (US) | 2009-08-12 | — | — | EP | claimed |
| WO-2008067566-A1 | COMPOSITIONS AND TREATMENTS COMPRISING 5-LIPOXYGENASE-ACTIVATING PROTEIN INHIBITORS AND NITRIC OXIDE MODULATORS | AMIRA PHARMACEUTICALS, INC. (US) | 2008-06-05 | — | — | WO | claimed |
| EP-2217589-A2 | MODULATORS OF OCULAR OXIDATIVE STRESS | ReVision Therapeutics, Inc. (US) | 2010-08-18 | — | — | EP | disclosed |
| EP-2086531-A1 | COMPOSITIONS AND TREATMENTS COMPRISING 5-LIPOXYGENASE-ACTIVATING PROTEIN INHIBITORS AND NITRIC OXIDE MODULATORS | Amira Pharmaceuticals, Inc. (US) | 2009-08-12 | — | — | EP | disclosed |
| WO-2009070693-A2 | MODULATORS OF OCULAR OXIDATIVE STRESS | SIRION THERAPEUTICS, INC (US) | 2009-06-04 | — | — | WO | disclosed |
| EP-2037951-A2 | METHODS AND COMPOSITIONS FOR TREATING OPHTHALMIC CONDITIONS VIA MODULATION OF MEGALIN ACTIVITY | Sirion Therapeutics, Inc. (US) | 2009-03-25 | — | — | EP | disclosed |
| EP-1807103-A4 | MODULATORS OF RETINOL-RETINOL BINDING PROTEIN (RBP)-TRANSTHYRETIN (TTR) COMPLEX FORMATION | SIRION THERAPEUTICS INC (US) | 2009-02-11 | — | — | EP | disclosed |
| EP-1904043-A4 | METHODS AND COMPOSITIONS FOR TREATING OPHTHALMIC CONDITIONS VIA SERUM RETINOL, SERUM RETINOL BINDING PROTEIN (RBP), AND/OR SERUM RETINOL-RBP MODULATION | SIRION THERAPEUTICS INC (US) | 2008-09-17 | — | — | EP | disclosed |
| WO-2008067566-A1 | COMPOSITIONS AND TREATMENTS COMPRISING 5-LIPOXYGENASE-ACTIVATING PROTEIN INHIBITORS AND NITRIC OXIDE MODULATORS | AMIRA PHARMACEUTICALS, INC. (US) | 2008-06-05 | — | — | WO | disclosed |
| EP-1804788-A4 | DETECTION AND ANALYSIS OF OPHTHALMICALLY-RELEVANT FLUORESCENT MOLECULES | SIRION THERAPEUTICS INC (US) | 2008-05-21 | — | — | EP | disclosed |
| EP-1827407-A4 | METHODS, ASSAYS AND COMPOSITIONS FOR TREATING RETINOL-RELATED DISEASES | SIRION THERAPEUTICS INC (US) | 2008-05-21 | — | — | EP | disclosed |
| EP-1827407-A2 | METHODS, ASSAYS AND COMPOSITIONS FOR TREATING RETINOL-RELATED DISEASES | Sirion Therapeutics, Inc. (US) | 2007-09-05 | — | — | EP | disclosed |
| EP-1807103-A2 | MODULATORS OF RETINOL-RETINOL BINDING PROTEIN (RBP)-TRANSTHYRETIN (TTR) COMPLEX FORMATION | Sirion Therapeutics, Inc. (US) | 2007-07-18 | — | — | EP | disclosed |
| EP-1804788-A2 | DETECTION AND ANALYSIS OF OPHTHALMICALLY-RELEVANT FLUORESCENT MOLECULES | Sirion Therapeutics, Inc. (US) | 2007-07-11 | — | — | EP | disclosed |
| EP-1768657-A1 | METHODS AND COMPOSITIONS FOR TREATING OPHTHALMIC CONDITIONS WITH RETINYL DERIVATES | Sirion Therapeutics, Inc. (US) | 2007-04-04 | — | — | EP | disclosed |
| WO-2007008821-A2 | METHODS AND COMPOSITIONS FOR TREATING OPHTHALMIC CONDITIONS VIA SERUM RETINOL, SERUM RETINOL BINDING PROTEIN (RBP), AND/OR SERUM RETINOL-RBP MODULATION | SIRION THERAPEUTICS, INC. (US) | 2007-01-18 | — | — | WO | disclosed |
| WO-2006063128-A2 | METHODS, ASSAYS AND COMPOSITIONS FOR TREATING RETINOL-RELATED DISEASES | SIRION THERAPEUTICS, INC. (US) | 2006-06-15 | — | — | WO | disclosed |
| WO-2006052860-A2 | MODULATORS OF RETINOL-RETINOL BINDING PROTEIN (RBP)-TRANSTHYRETIN (TTR) COMPLEX FORMATION | SIRION THERAPEUTICS, INC. (US) | 2006-05-18 | — | — | WO | disclosed |
| WO-2006047475-A2 | DETECTION AND ANALYSIS OF OPHTHALMICALLY-RELEVANT FLUORESCENT MOLECULES | SYTERA, INC. (US) | 2006-05-04 | — | — | WO | disclosed |
| WO-2006007314-A1 | METHODS AND COMPOSITIONS FOR TREATING OPHTHALMIC CONDITIONS WITH RETINYL DERIVATIVES | SIRION THERAPEUTICS, INC. (US) | 2006-01-19 | — | — | WO | disclosed |